COMMUNIQUÉS West-GlobeNewswire

Entera’s EB613, First-in-Class Oral PTH(1-34) Anabolic for Osteoporosis - Single Tablet Data Selected for Late Breaking Oral Presentation at ENDO 2026 Annual Meeting; Additional Oral Peptide Pipeline Data Accepted for Presentation
28/05/2026
TEL AVIV, May 28, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides, today announced that multiple abstracts across its oral peptide [...]
Sol-Gel Reports First Quarter 2026 Financial Results and Provides Corporate Updates
28/05/2026
Sol-Gel received a Notice of Allowance for a method-of-use patent extending intellectual property protection for topical patidegib (SGT-610) until 2044 Sol-Gel completed an oversubscribed underwritten offering, raising [...]
Thousands of people march to protest Ford’s hospital privatization, Demand he return that funding to our public hospitals
28/05/2026
TORONTO, May 28, 2026 (GLOBE NEWSWIRE) -- They are coming from towns across the province, where their local hospitals have been pushed into deficit and forced by the Ford government to make cuts. They are coming in the [...]
Celcuity To Participate in Upcoming Investor Conferences
28/05/2026
MINNEAPOLIS, May 28, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company focused on the development of targeted therapies for the treatment of multiple solid tumor indications, [...]
World Trade Center Health Program Launches National Awareness Initiative to Reach Those Who Were Impacted by 9/11 as Children or Teens
28/05/2026
New outreach initiative features New York City sketch artist and influencer Devon Rodriguez to reach individuals impacted by 9/11 at an early age and help them understand they may be eligible for no-cost medical [...]
SciSparc: Subsidiary NeuroThera Labs Received Conditional Regulatory Approval for Acquisition of CliniQuantum
28/05/2026
TEL AVIV, Israel, May 28, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a clinical-stage pharmaceutical company [...]
Aveanna Healthcare Announces Successful Debt Repricing
28/05/2026
ATLANTA, May 28, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (Nasdaq: AVAH), a leading, diversified home care platform focusing on providing care to medically complex, high-cost patient [...]
10X Health Launches New Supplements to Address Mobility & Circulation
28/05/2026
Rooted in science and clinically studied, 10X MoveEase™ and 10X Blood Flow Support™ are designed to improve overall daily performance and function SCOTTSDALE, Ariz., May 28, 2026 (GLOBE NEWSWIRE) -- 10X Health , a [...]
Aclaris Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference
28/05/2026
WAYNE, Pa., May 28, 2026 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today [...]
Conavi Medical Reports Fiscal Second Quarter 2026 Results and Operational Highlights
28/05/2026
- Achieves U.S. FDA 510(k) Clearance for Next-Generation Hybrid IVUS-OCT Imaging System - Wins Multiple Industry Awards Recognizing Innovation and Leadership in Intravascular Imaging - Advances U.S. Commercial Readiness [...]
Vor Bio to Participate in the 2026 Jefferies Global Healthcare Conference
28/05/2026
BOSTON, May 28, 2026 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that it will provide a corporate update in a [...]
FOXO TECHNOLOGIES, INC., FORMS STRATEGIC PARTNERSHIP WITH LONGEVITYFP TECHNOLOGIES, LLC. TO COMMERCIALIZE FOXO’S EPIGENETICS TECHNOLOGY
28/05/2026
WEST PALM BEACH, FL and MINNETONKA, MN, May 28, 2026 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (OTC: FOXO) (the “Company”) and LongevityFP Technologies, LLC. (“LFP”) today jointly announced a strategic partnership to [...]
PROCEPT BioRobotics® Advances Prostate Cancer Program with WATER IV Study Enrollment Completion and Expanded IDE Approval
28/05/2026
SAN JOSE, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) today announced two milestones in its WATER IV prostate cancer clinical program: completion of enrollment in the randomized WATER IV [...]
Oruka Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference
28/05/2026
MENLO PARK, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a clinical-stage biotechnology company developing novel biologics designed to set a new standard for the treatment [...]
Lexicon Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference
28/05/2026
THE WOODLANDS, Texas, May 28, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a fireside chat at the 2026 Jefferies Global Healthcare [...]
Enlivex Treasury Portfolio Update: RAIN Holdings Valued at Approximately $1.16 Billion; Rain Foundation Appoints Industry Leaders to Advisory Board
28/05/2026
As of May 27, 2026, Enlivex held 79,568,550,005 RAIN tokens with a total value of approximately $1.16 billion. Separately, the Rain Foundation recently announced the appointment of five industry leaders to its advisory [...]
Design Therapeutics to Participate in 2026 Jefferies Global Healthcare Conference
28/05/2026
CARLSBAD, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that [...]
Sapu Nano Unveils Progress in Deciparticle™ Nanomedicine Platform and AI-Driven Oncology Development at BIO 2026
28/05/2026
SAN DIEGO, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- via IBN -- Sapu Nano and Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”) today announced that Vuong Trieu, Chief Executive Officer, will present the [...]
MediPharm Labs Reminds Shareholders of Upcoming Annual and Special Meeting
28/05/2026
Annual and Special Meeting to be held virtually on Wednesday, June 17, 2026 at 11:00 a.m. (Eastern Time). The Board of Directors recommends shareholders vote FOR all director nominees and resolutions, before the 11:00 a [...]

Pages